Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MLL1-pioneered H3K4me3 modification on KLF7 promoter accelerates the invasion of fibroblast-like synoviocytes in rheumatoid arthritis. | In Vitro Cell Dev Biol Anim | 2026 | 41483084 | PubTator, text mining | PubMed |
| Discovery of a novel USP10 inhibitor with improved aqueous solubility for the treatment of hepatocellular carcinoma. | Bioorg Chem | 2026 | 41443012 | PubTator, text mining | PubMed |
| Synthesis and identification of a novel selective USP7 degrader that inhibits the migration of upper gastrointestinal cancer cells without affecting proliferation. | Eur J Med Chem | 2026 | 41418743 | PubTator, text mining | PubMed |
| YKT6 Promotes Bladder Cancer Progression by Stabilizing β-catenin Through USP7-Mediated Deubiquitination. | Adv Sci (Weinh) | 2026 | 41298248 | PubTator, text mining | PubMed |
| Clinical Impact of MTAP Rearrangement in Pediatric Acute Lymphoblastic Leukemia: Insights From Whole Transcriptome Analysis. | Pediatr Blood Cancer | 2026 | 41261957 | PubTator, text mining | PubMed |
| USP7 inhibitor P5091 enhances the antitumor efficacy of vemurafenib in BRAFV600E-mutant thyroid cancer via ferroptosis. | Biochem Pharmacol | 2026 | 41207567 | PubTator, text mining | PubMed |
| Ubiquitylation-oxaliplatin-related prognosis signature reveals the landscapes of immune responses, cell communication, and therapeutic sensitivity for colorectal cancer. | Anticancer Drugs | 2026 | 41191789 | PubTator, text mining | PubMed |
| TGFBR2 Accelerates the Oxidative Stress and Inflammation in Septic Acute Lung Injury VIA METTL14-MEDIATED M6A Modification or USP7-REGULATED Deubiquitination. | Shock | 2026 | 41166067 | PubTator, text mining | PubMed |
| CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma. | Cancer Res | 2026 | 40991301 | PubTator, text mining | PubMed |
| USP7 promotes follicular thyroid carcinoma progression and sorafenib resistance by activating NEK2/ATG5-mediated autophagy. | Histol Histopathol | 2026 | 40838301 | PubTator, text mining | PubMed |
| Avicularin induces apoptosis in NSCLC by promoting USP7-mediated degradation of FOXM1. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40788482 | PubTator, text mining | PubMed |
| FUS-stabilized USP7 facilitates the bevacizumab resistance of ovarian cancer through deubiquitinating PTK2. | J Gynecol Oncol | 2026 | 40784723 | PubTator, text mining | PubMed |
| METTL14 Promotes the Osteogenic Differentiation of Human Bone Marrow Stromal Cells via m6A-Dependent Stabilization of USP7 mRNA. | Biochem Genet | 2026 | 39815132 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Nanopore sequencing enables combined detection of USP7 variants and a known Hao-Fountain syndrome episignature. | Front Genet | 2025 | 41555921 | PubTator, text mining | PubMed |
| A Conserved Planthopper MATH-BTB Protein Regulates Fecundity in Nilaparvata legens Stål. | Int J Mol Sci | 2025 | 41516098 | PubTator, text mining | PubMed |
| Dynamic Gene Network Alterations and Identification of Key Genes in the Spleen During African Swine Fever Virus (ASFV) Infection. | Life (Basel) | 2025 | 41465783 | PubTator, text mining | PubMed |
| SPOP and HAUSP bidirectionally regulate LZTS2 ubiquitination to modulate the Wnt pathway. | Cell Death Dis | 2025 | 41436424 | PubTator, text mining | PubMed |
| USP7 promotes chemotherapy resistance and DNA damage response through stabilizing and deubiquitinating KDM4A in bladder cancer. | Cell Death Dis | 2025 | 41429764 | PubTator, text mining | PubMed |
| Immune-related deubiquitylation spectrum of microsatellite stability colorectal cancer reveals USP7 as a potential immunotherapeutic target. | Mol Cancer | 2025 | 41413544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=8